iPremom is a molecular diagnostics company based in Paterna, Valencia, focused on the earliest prediction of pregnancy complications. Founded in 2019 by Professor Carlos Simon and Dr Tamara Garrido and led by CEO Guillermo Ferrando Huertas, it developed the MaiRa platform, which analyses cell-free RNA signals from a single maternal blood sample to assess the risk of complications such as preeclampsia from week 9 of pregnancy, before symptoms appear. MaiRa was built on data from more than 26,000 samples linked to 10,000 pregnancies in the PREMOM prospective clinical study and is available in Spain through the company-owned laboratory.
1
Round
1
Industry
4
Tags
Sep 2, 2026
Latest raise
Funding activity · 1 round
Sep 2, 2026
EUR 15M
Seed
Led by Amadeus Capital Partners
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
